Mr Jack Latus | Novel Remote Monitoring Technology: Revolutionising Occupational Health Provision
The ever-growing applications of health technology have reached the world of occupational health. Mr Jack Latus from the Latus Group, based in the UK, endeavours to make the workplace safe, healthy, and productive. His company is one of the leading occupational health providers, paving the way for exploring new approaches to improve health in the workplace with pioneering technology to boost accessibility to occupational health services.
Importance of Occupational Health
According to the World Health Organization, the field of occupational health involves promoting and maintaining the highest degree of mental, social, and physical well-being of workers in all types of jobs. It aims to improve working conditions, ensure the work environment is safe and healthy, and maintain and promote employees’ health and working capacity. The practice involves a wide range of healthcare professionals and encompasses numerous activities, from creating policies for minimising the risk of workplace injuries to carrying out health checks.
Mr Jack Latus is the CEO and Co-founder of the Latus Group, a company that offers best-in-class occupational health services. These are utilised by many major contractors and businesses all over the UK. In an effort to make occupational health services more accessible, less time-consuming to administer, and cost-effective, Mr Latus explores the use of recently developed automated health technology for remote health surveillance.
Remote Automated Health Monitoring
Mr Latus and his team conducted a study assessing the viability of virtual health monitoring for particular remote occupational health surveillance activities, comparing them to traditional methods. They evaluated reliability, efficacy, and user acceptability to determine whether their remote monitoring technology could gather accurate health data while being user-friendly.
Mr Latus highlights that remote automated health monitoring has been successful in several areas of healthcare, such as remote monitoring of chronic obstructive pulmonary disease (COPD) patients. It helped remove barriers to healthcare, so patients did not have to travel long distances to access specialist clinics, saving time and money. He adds that utilising such technology in the field of occupational health could not only enhance access to essential health surveillance screening but could have additional benefits such as reducing staffing costs and assessment time. Currently, there are only enough qualified occupational health professionals to care for 55% of the UK workforce. Therefore, we must look to more efficient adoption of technologies to enable us to provide the level of care needed to keep our workforce fit for work.
YODHA: Remote Health Surveillance Box
The Latus Group boasts the world’s first connected health platform, YODHA, the remote health surveillance box. It offers an entirely digital occupational health service, eliminating the need for many of the time-consuming processes that are usually required. Newly developed technology was integrated into the current YODHA mobile screening kit and software for the study.
During their investigation, they collected two sets of data from the same 100 employees. For the first appointment, a technician assessed the employees in person using the standard health surveillance devices. During the second appointment, the employees used the ‘self-serve’ YODHA remote health surveillance box to gather their own health data unassisted. The team then analysed the readings from both appointments to see if the data collected by the novel technology aligned with that obtained during the in-person appointment.
The Testing
The study participants underwent several tests. During the in-person appointment with the technician, each employee had an audiometric test to assess their hearing using the Amplivox device, the gold-standard audiometric device. Next, their lung function was evaluated by spirometry using the Microbank spirometer. Lastly, their blood pressure and pulse rate were taken using an Omron blood pressure monitor.
During the unassisted remote assessment, the participants were instructed on how to use a YODHA remote health surveillance box. To help them understand the process, the instructions were available as written guidelines with images and a short video tutorial. Mr Latus highlights how the participants then proceeded to carry out all the same tests using YODHA, gathering their own audiometric, spirometry, blood pressure, and pulse rate readings.
Promising Results
Mr Latus and his team gathered very promising data with their study. They found few differences in the blood pressure, hearing, and spirometry measurements taken between the YODHA and traditional methods at particular frequencies and metrics. All comparison results between appointment 1 and appointment 2 were within 5% of each other, a variance we would expect between two separate appointments using the same equipment. Their report highlighted that there is a need for further refinement and calibration of the new technology. However, they also noted that the reliability of the self-administered tests greatly depended on the user’s ability to follow the instructions carefully.
The results from this initial research show a strong positive correlation across the various health measurements gathered. Mr Latus believes that this indicates remote health technology can be used to collect reliable data, which is vital for long-term health monitoring and enabling informed decisions regarding workplace health and safety. The team also noted that since automated remote assessments gather data comparable to that obtained during in-person appointments, such technology could help minimise human error and bias associated with a technician administering the tests.
The Future of Occupational Health Services
Mr Latus explains that using remote health monitoring technology, like the YODHA mobile screening kit, is a way to significantly boost accessibility to occupational health services, particularly for industries with remote locations or dispersed workers. It lets them carry out their own health assessments, fitting them in around work commitments and removing the need to travel to clinics or for occupational health practitioners to waste time travelling to customer sites. The technology also allows real-time and continuous monitoring of employees’ health, enabling prompt detection of any health problems and improved management of occupational health risks.
Mr Latus and his colleagues at the Latus Group are leading the way in integrating technology with providing occupational health services, and they highlight avenues for future research in this area. The next steps include working to improve the user interface and developing more extensive training on how to take accurate readings for the employees. The team also note the importance of maintaining consistent conditions during any remote assessments, like the ambient noise levels, which could affect the results of the hearing tests. Exploring approaches to mitigate such environmental variables could significantly impact the accuracy of the health measurements. Tackling these challenges is essential to maximise the advantages of remote health monitoring and guarantee its successful applications across various workplace environments.
After such a positive outcome on this robust data set, Latus now plans to move to a full market test to gather further data with the technology being used in industry, in January 2025, where it is planned for up to 40 businesses per month to get early access to use the equipment in the first quarter of 2025. Subject to a successful initial market test in Q1 2025, Latus plans to scale up the rollout to provide access to this advanced technology to all SMEs (small- and medium-sized enterprises) and large multi-site organisations throughout the rest of 2025, and market analysis estimates that by the end of 2026, approximately 25% of all health surveillance in the UK will be delivered via the YODHA technology.
SHARE
DOWNLOAD E-BOOK
REFERENCE
https://doi.org/10.33548/SCIENTIA1247
MEET THE RESEARCHERS
Mr Jack Latus
Latus Group Head Office, Chanterlands Avenue, Hull, UK
Mr Jack Latus is the Co-founder and CEO of the Latus Group, a prominent occupational health services company based in the UK. A graduate of Harvard Business School, Latus is deeply committed to enhancing workplace well-being and has spent his career creating innovative solutions to boost safety, productivity, and compliance. With his leadership, the Latus Group has earned a reputation for excellence in corporate healthcare and now serves as a key advisor to global brands and governments on improving access to occupational health through innovation. The Latus Group has a large team of medical professionals, which includes Occupational Health Nurses, Physicians, Occupational Health Technicians, Counsellors, Physiotherapists, and Rehabilitators to implement well-being initiatives, conduct health assessments, and ensure employees feel safe and healthy at work.
CONTACT
E: enquiries@latusgroup.co.uk
W: https://www.latusgroup.co.uk/
LinkedIn: www.linkedin.com/in/jack-latus
KEY COLLABORATORS
Dr Rebecca Vince, University of Hull, Health and Physiology Department
FUNDING
DWP and DHSC Innovation Contract: Improving Access to Occupational Health for UK Businesses
FURTHER READING
YODHA Viability Research Paper (full)
REPUBLISH OUR ARTICLES
We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more
Creative Commons Licence (CC BY 4.0)
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
SUBSCRIBE NOW
Follow Us
MORE ARTICLES YOU MAY LIKE
Professor James Calvin | Innovation in Heart Failure Care: Comparing Personal Coaching with Digital Support
Heart failure remains one of the most challenging conditions facing healthcare systems today, with hundreds of thousands of new cases diagnosed annually. Professor James Calvin from Western University’s Schulich School of Medicine and Dentistry has led groundbreaking research comparing two innovative approaches to supporting patients: personal health coaches and smartphone reminders. His team’s findings suggest that combining human support with digital technology could transform how we help patients manage this complex condition.
Dr Hermann Salmhofer | Minimising the Damage Caused by Systemic Viral Infections
The mechanisms via which viral diseases infect and progress within the human body have become the subject of intense scrutiny since the emergence of the serious respiratory condition COVID-19, although many other viruses remain woefully under-researched. Recently, Dr Hermann Salmhofer and colleagues at the Paracelsus Medical University in Salzburg, Austria, have described the successful treatment of a harmful systemic virus affecting the kidneys, and suggest a possible new treatment target to mitigate the progression of the disease and prevent the development of permanent organ damage. Their findings, combined with broader research on viral infections, highlight the critical importance of both preventive measures and targeted treatments in managing viral diseases.
Revealing the Intricate Links Between Metabolism and Reproduction
The brain plays a vital role in controlling reproductive functions. It helps to maintain a delicate balance of hormones, all of which can be affected by the metabolism. Investigating the impact of the metabolism on reproductive development and function is critical to a better understanding of health and diseases. Professor Carol Fuzeti Elias and Dr Cristina Sáenz de Miera Patín from the University of Michigan in the USA, carry out groundbreaking research in neuroscience, exploring the molecular and neural mechanisms at play.
Beating Bladder Cancer: Novel Treatment Combinations with CDK4/6 Inhibitors
Cancer is one of the leading causes of death around the world. Research into this disease is vital to the development of new treatments, bringing fresh hopes to those affected by this potentially devastating diagnosis. Dr Roman Nawroth and Dr Ting Hong carry out their ground-breaking research at the Technical University of Munich in Germany. They focus their efforts on novel approaches to fight bladder cancer, exploring the use of CDK4/6 inhibitors.